Companies / Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc.

Nasdaq: SNSECIK 1829802AUSTIN, TX

Financials

Revenue
Net income$-21.09M
Total debt$567.0K
Cash$26.90M
Diluted EPS$-16.72
Shares outstanding25.8M

Ownership

25.8M shares outstanding · as of Jul 30, 2026
1.1%10%+ / strategic
Ownership
10%+ / strategic1.09%281,717
Institutions0.63%163,610
Public float98.28%25,395,098

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
1.09%281,717
Parikh Anand KiranChief Operating Officer · Director

Institutional holders 15

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Millennium Management LLC
13F manager
New$4.62M+147K
146,565
0.57% of shares
low
Q1 2026
as of
Marshall Wace, LLP
13F manager
New$2.07M+66K
65,730
0.25% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
Add$646.9K+21K
+178.23%
32,041
0.12% of shares
low
Q1 2026
as of
Balyasny Asset Management L.P.
13F manager
New$510.8K+16K
16,205
0.06% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
New$299.5K+10K
9,501
0.04% of shares
low
Q2 2026
as of
BlackRock, Inc.
13F manager
New$85.0K+3K
3,402
0.01% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
Trim$-3.5K-325
-51.51%
306
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Trails Edge Capital Partners, LPPassive13G
Millennium Management LLCPassive13G/A
Millennium Management LLCPassive13G

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SNSE81728A207